Real-time enrollment status for this focal onset seizures clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 10:42 AM UTC
| NCT Number | NCT07141329 |
| Recruiting Status | Recruiting |
| Condition | Focal Onset Seizures |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Supernus Pharmaceuticals, Inc. |
| Last Updated on CT.gov | October 10, 2025 (Oct 10, 2025) |
As of July 21, 2026: Clinical trial NCT07141329 is currently recruiting participants. This phase2 study for focal onset seizures is actively seeking new participants at 1 location across the United States. The study is sponsored by Supernus Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07141329 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07141329 was last updated Oct 10, 2025 (October 10, 2025). HelloStudys verifies this status automatically.